Homburg Invest announces extension of listing on Euronext Amsterdam

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

MONTREAL, Sept. 4, 2012 /CNW Telbec/ - Homburg Invest Inc. (NYSE Euronext Amsterdam: HII) ("Homburg Invest" or the "Company") announced today that NSYE Euronext has honoured the request from Homburg Invest Inc. to extend the listing of the Company on Euronext Amsterdam for a period of six months.

As a result of the filing for the Canadian Companies' Creditors Arrangement Act (CCAA) in September 2011, NYSE Euronext reclassified the HII stock to a high risk trading group in accordance with the Euronext Rulebook. The Euronext Rulebook also provides for automatic delisting within a year from the start of the CCAA, unless there is sufficient evidence that the restructuring is being properly conducted and is expected to be effectuated within six months. This six-month period can be extended by a second term of maximum six months. Homburg Invest has succeeded in obtaining a first extension of six months owing to the prospects of a successful restructuring.

About Homburg Invest
Homburg Invest Inc. owns a diversified portfolio of commercial real estate including office, retail, industrial and development properties throughout Canada, Europe and the United States.

SOURCE: HOMBURG INVEST

For further information:

Media: 

Canada
Caroline Martel
NATIONAL Public Relations
(514) 843-2313
cmartel@national.ca

Netherlands
Heleen Jansen
Cohn & Wolfe
Tel 0031 (0)20 6768666
heleen.jansen@cohnwolfe.nl

Profil de l'entreprise

HOMBURG INVEST

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.